While Tandem Diabetes Care Inc has underperformed by -2.73%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TNDM rose by 15.97%, with highs and lows ranging from $47.00 to $13.82, whereas the simple moving average jumped by 67.33% in the last 200 days.
On April 29, 2024, Wells Fargo Upgraded Tandem Diabetes Care Inc (NASDAQ: TNDM) to Overweight. A report published by Leerink Partners on April 25, 2024, Upgraded its rating to ‘Outperform’ for TNDM. Stifel also Upgraded TNDM shares as ‘Buy’, setting a target price of $37 on the company’s shares in a report dated March 26, 2024. Citigroup August 04, 2023d the rating to Neutral on August 04, 2023, and set its price target from $45 to $33. BofA Securities May 05, 2023d its ‘Neutral’ rating to ‘Underperform’ for TNDM, as published in its report on May 05, 2023. UBS also rated the stock as ‘Neutral’.
Analysis of Tandem Diabetes Care Inc (TNDM)
Further, the quarter-over-quarter increase in sales is 13.16%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Tandem Diabetes Care Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -48.62% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.01, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 1.87M can be a very valuable indicator of volatility for TNDM stock. On a monthly basis, the volatility of the stock is set at 5.50%, whereas on a weekly basis, it is put at 7.26%, with a gain of 17.41% over the past seven days. Furthermore, long-term investors anticipate a median target price of $45.20, showing growth from the present price of $43.50, which can serve as yet another indication of whether TNDM is worth investing in or should be passed over.
How Do You Analyze Tandem Diabetes Care Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.67%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 112.72% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
TNDM shares are owned by institutional investors to the tune of 112.72% at present.
